Xoma | XOMA - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
AbbVie USD -6.66B 3.39B 2026-03
Agenus USD -221.22M 49.89M 2026-03
Agios Pharmaceuticals USD 1.11B 84M 2026-03
Ardelyx USD 148.62M 18.33M 2026-03
aTyr Pharma USD 57.93M 82.05M 2026-03
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Celldex Therapeutics USD 456.23M 70.94M 2026-03
Curis USD 5.46M 19.45M 2025-12
Eli Lilly USD 31.2B 4.66B 2026-03
Emergent BioSolutions USD 649.3M 47.9M 2023-12
Incyte USD 5.62B 455.37M 2026-03
MacroGenics USD 21.2M 34.39M 2026-03
Novartis USD 38.93B 7.2B 2026-03
Novartis USD 46.13B 1.8B 2025-12
Pfizer USD 90.1B 3.63B 2026-03
Prothena USD 312.62M 32.14M 2026-03
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Xoma USD 87.94M 15.5M 2025-09